MARKET

AVGR

AVGR

Avinger Inc
NASDAQ
3.099
+0.159
+5.41%
After Hours: 2.960 -0.139 -4.49% 19:35 03/28 EDT
OPEN
2.930
PREV CLOSE
2.940
HIGH
3.270
LOW
2.930
VOLUME
31.75K
TURNOVER
0
52 WEEK HIGH
18.00
52 WEEK LOW
2.500
MARKET CAP
5.28M
P/E (TTM)
-0.1330
1D
5D
1M
3M
1Y
5Y
Avinger (AVGR) Upgraded to Buy: What Does It Mean for the Stock?
NASDAQ · 3d ago
Weekly Report: what happened at AVGR last week (0318-0322)?
Weekly Report · 3d ago
Avinger Inc. on the Brink: The High Stakes of Navigating Chapter 11 Bankruptcy
TipRanks · 6d ago
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
FactSet Research Systems Inc. Shares dipped 5.2% to $462.36 on Thursday. The company reported worse-than-expected second-quarter revenue and issued FY24 guidance. Other stocks moving in the mid-day session include Bioscience, Inc. And Kaival Brands Innovations Group.
Benzinga · 03/21 18:39
HC Wainwright & Co. Reiterates Buy on Avinger, Maintains $5 Price Target
Benzinga · 03/21 15:23
Avinger’s Strategic Growth and Financial Outlook: A Buy Rating from Swayampakula Ramakanth
TipRanks · 03/21 15:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
10 Bioscience (NASDAQ:YTEN) stock increased by 133.7% to $0.57 during Thursday's pre-market session. The company's market cap is at $5.2 billion. Immunovant and argenx stock moved upwards by 14.0% and 13.24% respectively. Losers Tourmaline Bio and Avinger stock decreased by 33.4% during the pre- market session.
Benzinga · 03/21 13:05
Why Micron Therapies Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Shares of Micron Technology, Inc. Rose sharply in today's pre-market trading as the company reported upbeat results for its second quarter. Micron reported first-quarter revenue of $5.82 billion and issued strong third-quarter guidance. The company's shares jumped 17.1% to $112.69 in pre- market trading.
Benzinga · 03/21 12:05
More
About AVGR
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).

Webull offers Avinger Inc stock information, including NASDAQ: AVGR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVGR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVGR stock methods without spending real money on the virtual paper trading platform.